Percutaneous Left Atrial Appendage Occlusion-Current Evidence and Future Directions

Johannes Rotta Detto Loria1, Steffen Desch1, Janine Pöss1

  • 1Department of Cardiology, Heart Center Leipzig at University of Leipzig, 04289 Leipzig, Germany.

PubMed

Insights

Percutaneous left atrial appendage occlusion (LAAO) is a safe alternative to oral anticoagulation for stroke prevention in atrial fibrillation (AF) patients at high risk. This review evaluates LAAO

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Atrial fibrillation (AF) poses a significant stroke risk.
  • Oral anticoagulation (OAC) is standard but carries bleeding risks.
  • Left atrial appendage occlusion (LAAO) emerged as an alternative.

Purpose of the Study:

  • To systematically review percutaneous LAAO for stroke prevention in AF.
  • To evaluate anatomical considerations, patient selection, and procedural aspects.
  • To assess complications, post-procedural care, and outcomes.

Main Methods:

  • Systematic literature review.
  • Analysis of anatomical variations and patient criteria.
  • Evaluation of procedural techniques and safety data.
  • Review of contemporary outcome studies.

Main Results:

  • LAAO is a viable alternative to OAC in select AF patients.
  • Successful occlusion rates are high with low complication rates.
  • Patient selection and procedural planning are crucial for optimal outcomes.
  • Long-term data confirm efficacy and safety.

Conclusions:

  • Percutaneous LAAO is an effective stroke prevention strategy for high-risk AF patients.
  • Comprehensive understanding of anatomy and procedural nuances optimizes results.
  • LAAO offers a valuable therapeutic option reducing reliance on OAC.